Becton, Dickinson and Co. (BDX)
by | Posted 4.13.2012 | Post Comment (No Comments)

About Becton, Dickinson and Co. (BDX)

Becton, Dickinson and Co. is a global medical technology company engaged in the development, manufacture and sale of medical devices, instrument systems and reagents used by healthcare institutions, life science researchers, clinical laboratories, the pharmaceutical industry and the general public. BD’s operations consist of three business segments: BD Medical, BD Diagnostics and BD Biosciences. In August 2011, the Company acquired Carmel Pharma, AB. In February 2012, it acquired KIESTRA Lab Automation BV. In August 2012, the Company acquired Sirigen Group Limited, a developer of polymer dyes that are used in flow cytometry and can be applied to other technologies.

For more info: Becton, Dickinson and Co. Website, Becton, Dickinson and Co. Investor Relations

Recent Dividend Posts About Becton, Dickinson and Co. (BDX)

– Becton Dickinson (BDX) Dividend Stock Analysis @ Dividend-Growth-Stocks
Becton Dickinson Dividend Stock Analysis @ DividendGrowthStockInvesting
Becton, Dickinson and Co. (BDX) Dividend Stock Analysis @ Dividend-Growth-Stocks
Becton, Dickinson and Co. (BDX) Dividend Stock Analysis @ Dividend-Growth-Stocks
Becton Dickinson: Reasonable Value @ DividendMonk
Becton Dickinson (BDX) Dividend Stock Analysis @ DividendGrowthInvestor
Becton Dickinson 2013 Dividend Stock Analysis @ DividendMonk
Becton, Dickinson and Co. (BDX) Dividend Stock Analysis @ Dividend-Growth-Stocks

Becton, Dickinson and Co. (BDX)

[stocks s=”BDX”]